DRUG SURVIVAL AND TREATMENT RESPONSE RATES IN PSORIATIC ARTHRITIS PATIENTS SWITCHING TO FIRST- OR SECOND-LINE IL-17 INHIBITOR TREATMENT: A DANISH POPULATION-BASED COHORT STUDY

R. L. Hansen; T. S. Jørgensen; A. Egeberg; N. Lippert Rosenoe; M. Skougaard; Z. R. Stisen; L. Dreyer; L. E. Kristensen

doi:10.1136/annrheumdis-2022-eular.921

DRUG SURVIVAL AND TREATMENT RESPONSE RATES IN PSORIATIC ARTHRITIS PATIENTS SWITCHING TO FIRST- OR SECOND-LINE IL-17 INHIBITOR TREATMENT: A DANISH POPULATION-BASED COHORT STUDY

R. L. Hansen, T. S. Jørgensen, A. Egeberg, N. Lippert Rosenoe, M. Skougaard, Z. R. Stisen, L. Dreyer, L. E. Kristensen

Publikation: Bidrag til tidsskrift › Konferenceartikel i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	POS1018
Tidsskrift	Annals of the Rheumatic Diseases
Vol/bind	81
Udgave nummer	Suppl. 1
Sider (fra-til)	819-820
Antal sider	2
ISSN	0003-4967
DOI	https://doi.org/10.1136/annrheumdis-2022-eular.921
Status	Udgivet - jun. 2022
Begivenhed	Annual European Congress of Rheumatology, EULAR 2022 - Copenhagen, Danmark Varighed: 1 jun. 2022 → 4 jun. 2022 https://www.congress.eular.org/

Konference

Konference	Annual European Congress of Rheumatology, EULAR 2022
Land/Område	Danmark
By	Copenhagen
Periode	01/06/2022 → 04/06/2022
Internetadresse	https://www.congress.eular.org/

Bibliografisk note

Abstrakt No. POS1018

Adgang til dokumentet

10.1136/annrheumdis-2022-eular.921

Citationsformater

Hansen, R. L., Jørgensen, T. S., Egeberg, A., Rosenoe, N. L., Skougaard, M., Stisen, Z. R., Dreyer, L., & Kristensen, L. E. (2022). DRUG SURVIVAL AND TREATMENT RESPONSE RATES IN PSORIATIC ARTHRITIS PATIENTS SWITCHING TO FIRST- OR SECOND-LINE IL-17 INHIBITOR TREATMENT: A DANISH POPULATION-BASED COHORT STUDY. Annals of the Rheumatic Diseases, 81(Suppl. 1), 819-820. [POS1018]. https://doi.org/10.1136/annrheumdis-2022-eular.921

@inproceedings{b3b3d192e9784d1b8034f9594b57140a,

title = "DRUG SURVIVAL AND TREATMENT RESPONSE RATES IN PSORIATIC ARTHRITIS PATIENTS SWITCHING TO FIRST- OR SECOND-LINE IL-17 INHIBITOR TREATMENT: A DANISH POPULATION-BASED COHORT STUDY",

author = "Hansen, {R. L.} and J{\o}rgensen, {T. S.} and A. Egeberg and Rosenoe, {N. Lippert} and M. Skougaard and Stisen, {Z. R.} and L. Dreyer and Kristensen, {L. E.}",

note = "Abstract No. POS1018; Annual European Congress of Rheumatology, EULAR 2022 ; Conference date: 01-06-2022 Through 04-06-2022",

year = "2022",

month = jun,

doi = "10.1136/annrheumdis-2022-eular.921",

language = "English",

volume = "81",

pages = "819--820",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Suppl. 1",

url = "https://www.congress.eular.org/",

}

Hansen, RL, Jørgensen, TS, Egeberg, A, Rosenoe, NL, Skougaard, M, Stisen, ZR, Dreyer, L & Kristensen, LE 2022, 'DRUG SURVIVAL AND TREATMENT RESPONSE RATES IN PSORIATIC ARTHRITIS PATIENTS SWITCHING TO FIRST- OR SECOND-LINE IL-17 INHIBITOR TREATMENT: A DANISH POPULATION-BASED COHORT STUDY', Annals of the Rheumatic Diseases, bind 81, nr. Suppl. 1, POS1018, s. 819-820. https://doi.org/10.1136/annrheumdis-2022-eular.921

DRUG SURVIVAL AND TREATMENT RESPONSE RATES IN PSORIATIC ARTHRITIS PATIENTS SWITCHING TO FIRST- OR SECOND-LINE IL-17 INHIBITOR TREATMENT: A DANISH POPULATION-BASED COHORT STUDY. / Hansen, R. L.; Jørgensen, T. S.; Egeberg, A. et al.

I: Annals of the Rheumatic Diseases, Bind 81, Nr. Suppl. 1, POS1018, 06.2022, s. 819-820.

Publikation: Bidrag til tidsskrift › Konferenceartikel i tidsskrift › Forskning › peer review

TY - GEN

T1 - DRUG SURVIVAL AND TREATMENT RESPONSE RATES IN PSORIATIC ARTHRITIS PATIENTS SWITCHING TO FIRST- OR SECOND-LINE IL-17 INHIBITOR TREATMENT: A DANISH POPULATION-BASED COHORT STUDY

AU - Hansen, R. L.

AU - Jørgensen, T. S.

AU - Egeberg, A.

AU - Rosenoe, N. Lippert

AU - Skougaard, M.

AU - Stisen, Z. R.

AU - Dreyer, L.

AU - Kristensen, L. E.

N1 - Abstract No. POS1018

PY - 2022/6

Y1 - 2022/6

U2 - 10.1136/annrheumdis-2022-eular.921

DO - 10.1136/annrheumdis-2022-eular.921

M3 - Conference article in Journal

VL - 81

SP - 819

EP - 820

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - Suppl. 1

M1 - POS1018

T2 - Annual European Congress of Rheumatology, EULAR 2022

Y2 - 1 June 2022 through 4 June 2022

ER -

Hansen RL, Jørgensen TS, Egeberg A, Rosenoe NL, Skougaard M, Stisen ZR et al. DRUG SURVIVAL AND TREATMENT RESPONSE RATES IN PSORIATIC ARTHRITIS PATIENTS SWITCHING TO FIRST- OR SECOND-LINE IL-17 INHIBITOR TREATMENT: A DANISH POPULATION-BASED COHORT STUDY. Annals of the Rheumatic Diseases. 2022 jun.;81(Suppl. 1):819-820. POS1018. doi: 10.1136/annrheumdis-2022-eular.921